It is FDA-approved for weight loss and weight management in people with obesity or overweight plus a weight-related condition (e.g., high blood pressure)
You could imagine a world where appetites and calories consumed decrease, but, because people are thinner and eating less, they spend more of their calories on indulgences like snacks or dining out
In the EU and other regions, it faces similar restrictions
More research is needed to confirm its benefits, particularly with longer-term outcomes like live birth rates
Here's the thing nobody tells you about GLP-1 medications: the medication does its job incredibly wellmaybe too well
To our knowledge, this is one of the first large-scale projects in Norway specifically addressing land use and transport planning for walking, particularly in the context of small cities